DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Absorica Ld is a drug marketed by Sun Pharm and is included in one NDA. There are two patents protecting this drug.
This drug has seventeen patent family members in nine countries.
The generic ingredient in ABSORICA LD is isotretinoin. There are thirteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
A generic version of ABSORICA LD was approved as isotretinoin by AMNEAL PHARMS NY on September 29th, 2017.
|Country||Patent Number||Estimated Expiration|
|South Africa||201700843||Get Started for $10|
|European Patent Office||3200877||Get Started for $10|
|Russian Federation||2017106013||Get Started for $10|
|Japan||2017521470||Get Started for $10|
|World Intellectual Property Organization (WIPO)||2016051288||Get Started for $10|
|European Patent Office||3174601||Get Started for $10|
|>Country||>Patent Number||>Estimated Expiration|